Verapamil: here's the fair price
This is what US pharmacies pay, on average, for verapamil. Use it to spot a fair cash price, and feel good about asking for one.
Verapamil 80 Mg Tablet
A fair cash price is usually this cost plus a dispensing fee. If your quote is many times higher, ask about a generic, another pharmacy, or a cash discount.
Ask for generic Verapamil 80 Mg Tablet. Pharmacies pay about $2.15 for 30. Ask your pharmacy for its cash price and compare it with your copay. A fair cash price is close to this cost plus a dispensing fee.
Source: CMS NADAC as of 2026-11-04. Ask your prescriber or pharmacist whether a generic is right for you.
Source: CMS NADAC weekly file as of 2026-11-04. Median across NDCs with the same description. Public domain.
Your ZIP and location stay in your browser. We never store them.
Every strength and form
| Product | Pharmacy cost | 30 count | Effective |
|---|---|---|---|
| VERAPAMIL 80 MG TABLETGeneric | $0.07 per tablet or capsule | $2.15 | 10/21/2026 |
| VERAPAMIL 120 MG TABLETGeneric | $0.09 per tablet or capsule | $2.59 | 10/21/2026 |
| VERAPAMIL 40 MG TABLETGeneric | $0.11 per tablet or capsule | $3.37 | 10/21/2026 |
| VERAPAMIL ER 240 MG TABLETGeneric | $0.19 per tablet or capsule | $5.75 | 10/21/2026 |
| VERAPAMIL ER 180 MG TABLETGeneric | $0.19 per tablet or capsule | $5.83 | 10/21/2026 |
| VERAPAMIL ER 120 MG TABLETGeneric | $0.20 per tablet or capsule | $6.07 | 10/21/2026 |
| VERAPAMIL ER 180 MG CAPSULEGeneric | $2.83 per tablet or capsule | $84.84 | 10/21/2026 |
| VERAPAMIL SR 180 MG CAPSULEGeneric | $2.83 per tablet or capsule | $84.84 | 10/21/2026 |
| VERAPAMIL ER 120 MG CAPSULEGeneric | $2.92 per tablet or capsule | $87.48 | 10/21/2026 |
| VERAPAMIL SR 120 MG CAPSULEGeneric | $2.92 per tablet or capsule | $87.48 | 10/21/2026 |
| VERAPAMIL ER 240 MG CAPSULEGeneric | $3.43 per tablet or capsule | $102.76 | 10/21/2026 |
| VERAPAMIL SR 240 MG CAPSULEGeneric | $3.43 per tablet or capsule | $102.76 | 10/21/2026 |
| VERAPAMIL ER PM 100 MG CAPSULEGeneric | $4.11 per tablet or capsule | $123.31 | 10/21/2026 |
| VERAPAMIL ER PM 200 MG CAPSULEGeneric | $5.69 per tablet or capsule | $170.73 | 10/21/2026 |
| VERAPAMIL SR 360 MG CAPSULEGeneric | $7.61 per tablet or capsule | $228.32 | 10/21/2026 |
| VERAPAMIL ER PM 300 MG CAPSULEGeneric | $7.94 per tablet or capsule | $238.06 | 10/21/2026 |
Source: CMS NADAC, as of 2026-11-04. National average acquisition cost, not a retail quote.
Label basics
What it is used for (FDA label)
INDICATIONS AND USAGE Verapamil Hydrochloride Tablets are indicated for the treatment of the following: Angina 1. Angina at rest including: - Vasospastic (Prinzmetal’s variant) angina - Unstable (crescendo, pre-infarction) angina 2. Chronic stable angina (classic effort-associated angina) Arrhythmias 1. In association with digitalis for the control of ventricular rate at rest and during stress in patients with chronic atrial flutter and/or atrial fibrillation (see WARNINGS; Accessory bypass tract ) 2. Prophylaxis of repetitive paroxysmal supraventricular tachycardia Essential hypertension: Verapamil is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood...
Common side effects (FDA label)
ADVERSE REACTIONS Serious adverse reactions are uncommon when verapamil hydrochloride therapy is initiated with upward dose titration within the recommended single and total daily dose. See WARNINGS for discussion of heart failure, hypotension, elevated liver enzymes, AV block, and rapid ventricular response. Reversible (upon discontinuation of verapamil) non-obstructive, paralytic ileus has been infrequently reported in association with the use of verapamil. The following reactions to orally administered verapamil occurred at rates greater than 1% or occurred at lower rates but appeared...
Drug interactions (from the label)
Drug interactions Cytochrome inducers/inhibitors: In vitro metabolic studies indicate that verapamil is metabolized by cytochrome P450 CYP3A4, CYP1A2, CYP2C8, CYP2C9, and CYP2C18. Clinically significant interactions have been reported with inhibitors of CYP3A4 (e.g., erythromycin, ritonavir) causing elevation of plasma levels of verapamil while inducers of CYP3A4 (e.g., rifampin) have caused a lowering of plasma levels of verapamil. HMG-CoA reductase inhibitors: The use of HMG-CoA reductase inhibitors that are CYP3A4 substrates in combination with verapamil has been associated with reports of myopathy/rhabdomyolysis. Coadministration of multiple doses of 10 mg of verapamil with 80 mg...
Warnings (from the label)
WARNINGS Heart failure: Verapamil has a negative inotropic effect, which in most patients is compensated by its afterload reduction (decreased systemic vascular resistance) properties without a net impairment of ventricular performance. In clinical experience with 4,954 patients, 87 (1.8%) developed congestive heart failure or pulmonary edema. Verapamil should be avoided in patients with severe left ventricular dysfunction (e.g., ejection fraction less than 30%) or moderate to severe symptoms of cardiac failure and in patients with any degree of ventricular dysfunction if they are receiving a beta-adrenergic blocker (see PRECAUTIONS, Drug Interactions ). Patients with milder ventricular...
Source: FDA drug label via openFDA, label effective 2024-05-22. Full label on DailyMed. Excerpts are verbatim and truncated. Read the full label and ask your pharmacist.